BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2480377)

  • 21. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1991 Sep; 147(6):1786-91. PubMed ID: 1890304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time dependence of B cell processing and presentation of peptide and native protein antigens.
    Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK
    J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
    Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
    Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen.
    Accapezzato D; Nisini R; Paroli M; Bruno G; Bonino F; Houghton M; Barnaba V
    J Immunol; 1998 Jun; 160(11):5262-6. PubMed ID: 9605122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.
    Nisini R; Romagnoli G; Gomez MJ; La Valle R; Torosantucci A; Mariotti S; Teloni R; Cassone A
    Infect Immun; 2001 Jun; 69(6):3728-36. PubMed ID: 11349037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.
    James EA; Bui J; Berger D; Huston L; Roti M; Kwok WW
    Int Immunol; 2007 Nov; 19(11):1291-301. PubMed ID: 17906339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophages as stimulators of MART-1 27-35 epitope-specific human cytolytic T lymphocytes in vitro.
    Mehrotra S; Zaidi N; Chakraborty NG; Mukherji B
    Pathobiology; 2006; 73(5):238-43. PubMed ID: 17314494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.
    Chromik J; Schnürer E; Georg Meyer R; Wehler T; Tüting T; Wölfel T; Huber C; Herr W
    J Immunol Methods; 2006 Jan; 308(1-2):77-89. PubMed ID: 16336973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anergy induction in human CD4+ T-cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL4 production.
    Grunow R; Frutig K; Pichler WJ
    Cell Immunol; 1996 Oct; 173(1):79-86. PubMed ID: 8871603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.
    Schnyder B; Mauri-Hellweg D; Zanni M; Bettens F; Pichler WJ
    J Clin Invest; 1997 Jul; 100(1):136-41. PubMed ID: 9202065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect.
    Ashwell JD; Jenkins MK; Schwartz RH
    J Immunol; 1988 Oct; 141(8):2536-44. PubMed ID: 2844902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
    Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
    Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
    Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.
    Valmori D; Sabbatini A; Lanzavecchia A; Corradin G; Matricardi PM
    J Immunol; 1994 Mar; 152(6):2921-9. PubMed ID: 7511633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y; Sugamura K; Hinuma Y
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.